Tariff-struck companies exploring loans backed by refund claims​

Importers are pursuing roughly $166 billion in refunds from Trump-era tariffs struck down by the U.S. Supreme Court, and some are using those refund claims as collateral to obtain term loans rather than selling claims at deep discounts. Lenders reportedly require minimum loan sizes of ~$10m backed by claims of at least ~$20m; smaller claims (e.g., $500k) are trading at roughly $0.55–$0.75 on the dollar. Loans are structured with payment-in-kind interest and carry material risks (collateral erosion, borrower default); at a hypothetical 15% interest rate, borrowing vs. selling a claim at $0.80 breaks even in just over two years. Financial buyers plan to deploy billions and brokers have already arranged about $20m in claim purchases to date.

Analysis

The emergence of tariff-refund claims as collateral creates a novel, idiosyncratic asset class whose value is driven more by administrative throughput and litigation tail-risks than by macro credit cycles. That makes mark-to-model volatility high: lenders will demand sweeping covenants and dynamic haircuts to protect against abrupt shifts in eligibility or processing pace, turning what looks like a trade receivable into a quasi-litigation loan. Expect secondary pricing to remain path-dependent — tight when refund timelines shorten and wide when procedural friction or appeals appear — producing episodic liquidity windows for sellers and acute collateral erosion for lenders.

Banks and private-credit funds that lean in will shift underwriting resources: specialist tax, customs, and class-action legal diligence will become underwriter bottlenecks, not borrower cashflow forecasts. That raises second-order supply-chain friction — importers who hold claims as collateral may delay sourcing changes or pass through costs differently, creating uneven demand signals for suppliers in Asia and distributors in the U.S. simultaneously. Meanwhile, a growing market for contingency insurance and post-acquisition indemnities will create new revenue streams for legal/insurance intermediaries while concentrating operational risk in a handful of specialist underwriters.

Critical catalysts are administrative pipeline milestones and insurer appetite: an operational refund framework or scalable insurance product would materially compress yields and force buyers to compete for claims, while prolonged regulatory reviews or successful appeals would widen spreads and increase defaults. Time horizon: expect decisive moves within 6–24 months as processes and insurance products scale, but tail litigation risk can extend realizations into multi-year corridors. Monitor claim-transfer volumes and insurance issuance as high-frequency proxies for market direction.

The most important strategic implication for investors is to treat these instruments as credit bets with a legal-duration overlay, not as trade receivables. Position sizing should assume sudden 30–60% collateral repricing scenarios; prefer exposure through specialist managers or insurance sellers rather than bilateral loans on sponsor balance sheets unless you control remediation rights and legal cooperation covenants.

Key Decisions for Investors

• Long BUR (Burford): 6–18 month trade to capture rising demand for litigation/claims finance. Target +40% upside if market growth continues and insurance products proliferate; downside -30% if legal outcomes centralize or reforms limit recoveries. Size as a satellite (<=2% portfolio).
• Buy RYAN (RYAN): 6–12 month tactical buy for advisory/implementation services expansion as buyers seek contingency insurance and tax/recovery counsel. Expect modest revenue uplift; risk is execution and cyclical client slowdown. Take partial profits on a 25–30% move.
• Long ARCC (Ares Capital) or GBDC (Golub) via 3–12 month exposure to pick up elevated private-credit spreads from specialty term loans, but hedge with 1–2 year investment-grade corporate CDS to protect against systemic widening. Reward: extra yield; Risk: collateral erosion—cap position at 3–5% NAV and use credit hedge costing ~150–300bps.
• Pair trade: Long specialist litigation finance/insurance names (BUR) and short selected mid-cap retail credits with thin margins and potential consumer recourse (example: discretionary-retail bond CDS). Timeframe 6–18 months. This captures divergence if claim buyers drive litigation finance pricing while retailers face recourse pressures; maintain stop-loss of 15–20% on the short leg.